期刊文献+

NBAP测定在儿童佝偻病诊断中的临床探究 被引量:2

A clinical study on detection of bone alkaline phosphatase(BAP)for diagnosis of children(?) tickets
下载PDF
导出
摘要 目的筛查儿童佝偻病发生情况,探讨骨源性碱性磷酸酶在儿童佝偻病诊断中的价值,以降低漏诊率,提高治疗效果。方法选取佝偻病患病组和随机抽取对照组进行骨源性碱性磷酸酶测定。结果骨源性碱性磷酸酶在对照组中≤200U/L的儿童占51.5%,而患病组中≤200U/L的儿童仅占3.9%,患病儿童中96.1%的儿童骨源性碱性磷酸酶>200U/L,且患儿病情越重,骨源性碱性磷酸酶活性越高。结论骨源性碱性磷酸酶的测定,为儿童佝偻病的诊断提供了有价值的手段。同时也提示,本地区佝偻病发生率仍很高,应引起高度重视。 Objective To investigate morbidity of children's rickets in our district and to evaluate clinical value of detection of bone alkaline phosphatase for diagnosis of rickets so as to decrease the missed diagnosis rate and improve therapeutic effect of the disease. Methods Bone alkaline phosphatase was detected with NBAP KIT( produced by ZS-Kingmed) for children with rickets and normal children as controls who were selected randomly. Results BAP value of 3.9 % of children with rickets was 〈200U/L, while that of 51.5 of normal control children was 〈200U/L. BAP value of 96.1% of children with tickets was 〉200U/L, and the more severe the children's rickets, the higher the activity of BAP. Conclusion Detection of bone alkaline phosphatase provides a valuable means for diagnosis of rickets. Meanwhile, it suggested that the prevalence of rickets among children is high in this district and more attention should be paid.
出处 《中国妇幼健康研究》 2006年第4期273-274,共2页 Chinese Journal of Woman and Child Health Research
关键词 佝偻痛 骨源性碱性磷酸酶 儿童 病例对照研究 rickets bone alkaline phosphatase (BAP) children case control study
  • 相关文献

参考文献4

二级参考文献23

  • 1张茵.天津市13344名儿童钙营养状况分析[J].中国妇幼保健杂志,1998,13(3):151-151.
  • 2[1]NIH Consensus Development Panel on Osteoporosis Prevention. Diagnosis and Therapy. JAMA 2001,285:785-795.
  • 3[2]Weinstein RS. True strength. J Bone Miner Res 2000,15:621-625.
  • 4[3]Chesnut Ⅲ CH, Rosen CJ for the Bone Quality Discussion Group. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res 2001,16:2163-2172.
  • 5[4]Marcus R, Wong M, Heath Ⅲ H, et al. Antiresorptive treatment of posrmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocrine Rev 2002,23:16-37.
  • 6[5]Orimo H, Hayashi Y, Fukunaga M, et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001,19:331-337.
  • 7[6]Cummings SR, Karpf DB, Harris F, et al. Improvement of spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002,112: 282-289.
  • 8[7]Heaney RP. Is the paradigm shifting? Bone 2003,33:457-465.
  • 9[8]Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women; EPIDOS prospective study. J Bone Mineral Res 1996,11:1531-1538.
  • 10[9]Garnero P, Sornay-Rendu E, Claustrar B, et al. Biochemical markers of bone turnover, endogenous hormones and the risk of fracture in postmenpausal women: the OFELY study. J Bone Miner Res 2000, 15: 1526-1536.

共引文献25

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部